Copied to clipboard!
c-TRAK-CN : clonal evolution
In patients with moderate to high risk TNBC enrolled in the c-TRAK clinical trial, we exome sequenced 238 primary tumour-tissue samples from 149 patients, alongside tissue digital and multiplex-immunofluorescence pathology, to investigate factors associated with the development of Molecular Residual Disease (MRD) after curative intent therapy. We investigated tumour evolution from MRD detection to relapse in 291 ctDNA samples from 56 patients.
- Type: Exome Sequencing
- Archive: European Genome-phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
| Dataset ID | Description | Technology | Samples |
|---|---|---|---|
| EGAD50000003204 | unspecified | 397 |
